USE OF CGRP ANTAGONIST FOR THE TREATMENT OF PRURITUS AND OCULAR OR PALPEBRAL DYSAESTHESIAS

摘要

Use of at least one calcitonin gene related peptide (CGRP) antagonist in and/or for the prepn. of a pharmaceutical and/or dermatological compsn. for the treatment of ocular and/or palpebral (eyelid) dysesthesia and/or pain and/or pruritus is new. The compsns. are claimed per se.